Infection with HPVs is a major public health burden, associated with benign warts as well as cervical carcinoma. Prevention or elimination of these infections would benefit the numerous patients with benign lesions and reduce the incidence of cervical cancer. Although prophylactic vaccines to block genital HPV infection have become available, there is still a population of infected individuals without a specific therapy. We discussed the functions of the viral proteins that appear to be the most appropriate for the development of therapeutics aimed at the treatment of viral-induced diseases.
COBISS.SI-ID: 1391099